Renaissance Capital logo

Theraplant (Greenrose Acquisition) Priced, Nasdaq: GNRS

Blank check company targeting the cannabis industry (completed 11/29/2021).

Industry: SPAC

First Day Return: +0.7%

Industry: SPAC

We are a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities, which we refer to as a “target business.” To date, our efforts have been limited to organizational activities as well as activities related to this. Our initial business combination and value creation strategy will be to identify, acquire and, after our initial business combination, assist in the growth of a business in the cannabis industry. However, we are not limited to this industry and we may pursue a business combination opportunity in any business or industry we choose and we may pursue a company with operations or opportunities outside of the United States.
more less
IPO Data
IPO File Date 12/27/2019
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 15.0
Deal Size ($mm) $150
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 02/10/2020
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $150
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Woodbury, NY, United States
Founded 2019
Employees at IPO 5
Website www.greenrosecorp.com

Theraplant (Greenrose Acquisition) (GNRS) Performance